Skip to Main Content

Author Details

Junjie T Hua
School of Public Health, Sun Yat-sen University
2016
18
12
PMIDPaper TitleJournal TitlePublished Year
36334679Histological types of lung cancer attributable to fine particulate, smoking, and genetic susceptibility.Sci Total Environ2023
37234978Recent advances in understanding DNA methylation of prostate cancer.Front Oncol2023
36251389The 5-Hydroxymethylcytosine Landscape of Prostate Cancer.Cancer Res2022
35672787Automated whole-slide images assessment of immune infiltration in resected non-small-cell lung cancer: towards better risk-stratification.J Transl Med2022
36309516The cell-free DNA methylome captures distinctions between localized and metastatic prostate tumors.Nat Commun2022
34326322An integrated functional and clinical genomics approach reveals genes driving aggressive metastatic prostate cancer.Nat Commun2021
33741908CRISPRi screens reveal a DNA methylation-mediated 3D genome dependent causal mechanism in prostate cancer.Nat Commun2021
31974375Noncoding mutations target cis-regulatory elements of the FOXA1 plexus in prostate cancer.Nat Commun2020
30655535ONECUT2 is a driver of neuroendocrine prostate cancer.Nat Commun2019
31623872Landscape of Noncoding RNA in Prostate Cancer.Trends Genet2019
30735634Widespread and Functional RNA Circularization in Localized Prostate Cancer.Cell2019
31032301Orphan noncoding RNAs: novel regulators and cancer biomarkers.Ann Transl Med2019
30033362Risk SNP-Mediated Promoter-Enhancer Switching Drives Prostate Cancer through lncRNA PCAT19.Cell2018
30212448Refined RIP-seq protocol for epitranscriptome analysis with low input materials.PLoS Biol2018
27885842Crucial role of noncoding RNA in driving prostate cancer development and progression.Epigenomics2017
29754555Noncoding RNA for personalized prostate cancer treatment: utilizing the 'dark matters' of the genome.Per Med2017
28916652LSD1-Mediated Epigenetic Reprogramming Drives CENPE Expression and Prostate Cancer Progression.Cancer Res2017
27526323Modulation of long noncoding RNAs by risk SNPs underlying genetic predispositions to prostate cancer.Nat Genet2016
  • 1 - 18 of 18

Recommended Authors

Yang Liu
Veracyte inc.
Career Start Year 2019
Number of shared co-authors 27
Connor Bell
Dana-Farber Cancer Institute
Career Start Year 2018
Number of shared co-authors 37
Sinja Taavitsainen
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 2018
Number of shared co-authors 13
Christianne Hoey
Evaluative Clinical Sciences, Sunnybrook Research Institute
Career Start Year 2017
Number of shared co-authors 16
Edward O'Connor
Dana-Farber Cancer Institute
Career Start Year 2017
Number of shared co-authors 37
Michael Sigouros
Caryl and Israel Englander Institute for Precision Medicine
Career Start Year 2017
Number of shared co-authors 15
Wei Yuan
The Institute for Cancer Research
Career Start Year 2015
Number of shared co-authors 8
Travis Gerke
The Prostate Cancer Clinical Trials Consortium
Career Start Year 2014
Number of shared co-authors 14
Joshua Armenia
Oncology R&D
Career Start Year 2013
Number of shared co-authors 9
Ren?? B??ttcher
Universitat Pompeu Fabra
Career Start Year 2012
Number of shared co-authors 13
Alejandro Athie
Vall d'Hebron Institute of Oncology (VHIO)
Career Start Year 2012
Number of shared co-authors 3
Varune R Ramnarine
University of British Columbia
Career Start Year 2011
Number of shared co-authors 27
Fubo Wang
Center for Genomic and Personalized Medicine, Guangxi Medical University
Career Start Year 2011
Number of shared co-authors 12
Adam G Sowalsky
National Cancer Institute
Career Start Year 2010
Number of shared co-authors 23
Suhn K Rhie
Keck School of Medicine of USC
Career Start Year 2009
Number of shared co-authors 4
Mohammed Alshalalfa
University of Miami Miller School of Medicine/Sylvester Comprehensive Cancer Center
Career Start Year 2009
Number of shared co-authors 43
Alfonso Urbanucci
Northwestern University Feinberg School of Medicine Chicago
Career Start Year 2008
Number of shared co-authors 17
Anne Haegert
University of British Columbia
Career Start Year 2008
Number of shared co-authors 29
Verena Sailer
Institute for Pathology, University Hospital Schleswig-Holstein
Career Start Year 2007
Number of shared co-authors 7
Svitlana Tyekucheva
Dana-Farber Cancer Institute
Career Start Year 2006
Number of shared co-authors 8
Charlie E Massie
University of Cambridge
Career Start Year 2003
Number of shared co-authors 5
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 3
Christopher E Barbieri
Weill Cornell Medical College
Career Start Year 2003
Number of shared co-authors 14
Luke A Selth
Adelaide Medical School, University of Adelaide
Career Start Year 2002
Number of shared co-authors 18
Sooryanarayana Varambally
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year 2001
Number of shared co-authors 7
Xuhong Cao
Michigan Center for Translational Pathology.
Career Start Year 1999
Number of shared co-authors 13
Srinivasan Yegnasubramanian
Johns Hopkins University School of Medicine
Career Start Year 1999
Number of shared co-authors 10
Hayley C Whitaker
University College London
Career Start Year 1999
Number of shared co-authors 4
Hidewaki Nakagawa
RIKEN Center for Integrative Medical Sciences
Career Start Year 1994
Number of shared co-authors 12
Arul M Chinnaiyan
University of Michigan Medical School.
Career Start Year 1993
Number of shared co-authors 59

Collaborators

Housheng Hansen He
Princess Margaret Cancer Center, University Health Network, University of Toronto
Co-authored papers 14
Fraser Soares
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 10
Haiyang Guo
the Second Hospital, Cheeloo College of Medicine, Shandong University
Co-authored papers 9
Musaddeque Ahmed
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 9
Felix Y Feng
UCSF Medical Center-Mount Zion
Co-authored papers 9
Paul C Boutros
University of California los angeles
Co-authored papers 8
Sujun Chen
Princess Margaret Cancer Center/University Health Network
Co-authored papers 8
Michael Fraser
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 6
Theodorus H van der Kwast
University Health Network, University of Toronto
Co-authored papers 6
Amina Zoubeidi
University of British Columbia
Co-authored papers 5
Yi Liang
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 4
Mathieu Lupien
Princess Margaret Cancer Research Centre
Co-authored papers 4
Yong Zeng
College of Life Science, Hunan Normal University
Co-authored papers 4
Miranda Wang
Princess Margaret Cancer Center/University Health Network
Co-authored papers 4
Robert G Bristow
University of Toronto
Co-authored papers 4
Stanley Zhou
Princess Margaret Cancer Research Centre
Co-authored papers 3
Trevor J Pugh
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 3
David A Quigley
University of California-San Francisco
Co-authored papers 3
Jiansheng Guan
Princess Margaret Cancer Center, University Health Network
Co-authored papers 3
Ming-Sound Tsao
University Health Network, University of Toronto
Co-authored papers 3
Yuzhe Zhang
China University of Mining and Technology
Co-authored papers 3
Martin Sj??str??m
University of California-San Francisco
Co-authored papers 2
Martin E Gleave
University of British Columbia
Co-authored papers 2
Christine Poon
Royal North Shore Hospital
Co-authored papers 2
Cindy Q Yao
Ontario Institute for Cancer Research
Co-authored papers 2
Jens Langstein
German Cancer Research Center (DKFZ) & National Center for Tumor Diseases (NCT)
Co-authored papers 2
Eric J Small
University of California san francisco
Co-authored papers 2
Parisa Mazrooei
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2
Luke A Gilbert
Arc Institute
Co-authored papers 2
Raunak Shrestha
University of California San Francisco
Co-authored papers 2
Release 1.2